OAMU
BMY icon

Ostrum Asset Management US’s Bristol-Myers Squibb BMY Stock Holding History

Ostrum Asset Management US’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,879
Closed -$1.03M – 64
2018
Q4 		$1.03M Buy
+19,879
New +$1.07M 0.15% 85

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Ostrum Asset Management US's BMY Position: Q1 2019 in Review

Ostrum Asset Management US sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 19,879 shares — an estimated $1.03M sold.

Ostrum Asset Management US first reported a position in BMY in Q4 2018 and held it in 1 quarter. The position peaked at $1.03M in Q4 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Ostrum Asset Management US reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Ostrum Asset Management US sold 19,879 Bristol-Myers Squibb shares in Q1 2019, an estimated $1.03M.
  • Ostrum Asset Management US first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 1 quarter.
  • Ostrum Asset Management US's Bristol-Myers Squibb position peaked at $1.03M in Q4 2018.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.